Methenamine Hippurate Tablet
Product Images NDC 50268-549

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 50268-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1g (549 15 1g 50ct)

This is a prescription-only medication with the NDC code 50268-549-15, containing methenamine hippurate in tablet form. Each tablet contains 1 g of methenamine hippurate, USP. The package contains 50 tablets arranged in a 5 x 10 Unit Dose format. The instructions for use are available in the package insert. It is important to store the tablets between 20°C to 25°C (68°F to 77°F), with temperature excursions permitted between 15° and 30°C (59°F to 86°F), and to keep the drugs out of reach of children. The manufacturer of the drug is AVKARE, located in Pulaski, TN 38478.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.